BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 1381218)

  • 1. A phase I trial of recombinant gamma interferon in patients with cancer.
    Foon KA; Sherwin SA; Abrams PG; Stevenson HC; Holmes P; Maluish AE; Oldham RK; Herberman RB
    Cancer Immunol Immunother; 1985; 20(3):193-7. PubMed ID: 3933818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and immunological responses of hairy cell leukemia patients to interferon beta.
    Liberati AM; Horisberger M; Schippa M; Di Clemente F; Fizzotti M; Filippo S; Proietti MG; Arzano S; Berruto P; Palmisano L
    Cancer Immunol Immunother; 1991; 34(2):115-22. PubMed ID: 1760815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil functions in patients with neutropenia due to glycogen storage disease type 1b treated with empagliflozin.
    Kaczor M; Malicki S; Folkert J; Dobosz E; Bryzek D; Chruścicka-Smaga B; Greczan M; Wesół-Kucharska D; Piatosa B; Samborowska E; Madzio J; Książyk J; Vel Emczyńska EE; Hajdacka M; Potempa J; Młynarski W; Rokicki D; Veillard F
    Blood Adv; 2024 Mar; ():. PubMed ID: 38531056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering a New IFN-ApoA-I Fusion Protein with Low Toxicity and Prolonged Action.
    Miroshnichenko S; Pykhtina M; Kotliarova A; Chepurnov A; Beklemishev A
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia.
    Frampton JE; Lee CR; Faulds D
    Drugs; 1994 Nov; 48(5):731-60. PubMed ID: 7530630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hairy-cell leukemia.
    Lill MC; Golde DW
    Blood Rev; 1990 Dec; 4(4):238-44. PubMed ID: 1706207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of interferon in the treatment of hairy cell leukemia.
    Ratain MJ; Vardiman JW; Golomb HM
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):21-8. PubMed ID: 3532332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
    Glaspy JA; Souza L; Scates S; Narachi M; Blatt L; Ambersley J; Golde DW
    J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte colony-stimulating factor (rh G-CSF) as an adjunct to interferon alpha therapy of neutropenic patients with hairy cell leukemia.
    Lorber C; Willfort A; Ohler L; Jäger U; Schwarzinger I; Lechner K; Geissler K
    Ann Hematol; 1993 Jul; 67(1):13-6. PubMed ID: 7687471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor.
    Glaspy JA; Baldwin GC; Robertson PA; Souza L; Vincent M; Ambersley J; Golde DW
    Ann Intern Med; 1988 Nov; 109(10):789-95. PubMed ID: 2461131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
    Hasselbalch H; Braide I; Lisse I; Röckert LL; Swolin B; Carneskog J; Hagberg H; Hippe E; Jensen MK; Lundin P
    Eur J Haematol; 1988 Nov; 41(5):438-44. PubMed ID: 3061836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
    Smith JW; Longo DL; Urba WJ; Clark JW; Watson T; Beveridge J; Conlon KC; Sznol M; Creekmore SP; Alvord WG
    Blood; 1991 Oct; 78(7):1664-71. PubMed ID: 1912555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.
    Ratain MJ; Golomb HM; Vardiman JW; Westbrook CA; Barker C; Hooberman A; Bitter MA; Daly K
    J Clin Oncol; 1988 Nov; 6(11):1714-21. PubMed ID: 3054003
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.